61 related articles for article (PubMed ID: 6690060)
21. Repair of O6-methyl-guanine residues in DNA takes place by a similar mechanism in extracts from HeLa cells, human liver, and rat liver.
Myrnes B; Giercksky KE; Krokan H
J Cell Biochem; 1982; 20(4):381-92. PubMed ID: 7183679
[TBL] [Abstract][Full Text] [Related]
22. Cells deficient in DNA polymerase beta are hypersensitive to alkylating agent-induced apoptosis and chromosomal breakage.
Ochs K; Sobol RW; Wilson SH; Kaina B
Cancer Res; 1999 Apr; 59(7):1544-51. PubMed ID: 10197627
[TBL] [Abstract][Full Text] [Related]
23. Role of O6-methylguanine-DNA methyltransferase in the resistance of pancreatic tumors to DNA alkylating agents.
Kokkinakis DM; Ahmed MM; Delgado R; Fruitwala MM; Mohiuddin M; Albores-Saavedra J
Cancer Res; 1997 Dec; 57(23):5360-8. PubMed ID: 9393761
[TBL] [Abstract][Full Text] [Related]
24. Decreased host-cell reactivation of UV-irradiated adenovirus in human colon tumor cell lines that have normal post-UV survival.
Day RS; Rasouli-Nia A; Meservy J; Lari SU; Dobler K; Tsunoda S; Miyakoshi J; Takebe H; Murray D
Photochem Photobiol; 1999 Aug; 70(2):217-27. PubMed ID: 10461460
[TBL] [Abstract][Full Text] [Related]
25. Glial cell-specific differences in repair of O6-methylguanine.
LeDoux SP; Williams BA; Hollensworth BS; Shen C; Thomale J; Rajewsky MF; Brent TP; Wilson GL
Cancer Res; 1996 Dec; 56(24):5615-9. PubMed ID: 8971165
[TBL] [Abstract][Full Text] [Related]
26. Reduced level of DNA cross-links and sister chromatid exchanges in 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant rat brain tumor cells.
Bodell WJ; Rupniak HT; Rasmussen J; Morgan WF; Rosenblum ML
Cancer Res; 1984 Sep; 44(9):3763-7. PubMed ID: 6744295
[TBL] [Abstract][Full Text] [Related]
27. Strand- and sequence-specific attenuation of N-methyl-N'-nitro-N-nitrosoguanidine-induced G.C to A.T transitions by expression of human 6-methylguanine-DNA methyltransferase in Chinese hamster ovary cells.
Yang JL; Hsieh FP; Lee PC; Tseng HJ
Cancer Res; 1994 Jul; 54(14):3857-63. PubMed ID: 8033107
[TBL] [Abstract][Full Text] [Related]
28. O6-methylguanine-DNA methyltransferase-deficient phenotype in human gliomas: frequency and time to tumor progression after alkylating agent-based chemotherapy.
Silber JR; Blank A; Bobola MS; Ghatan S; Kolstoe DD; Berger MS
Clin Cancer Res; 1999 Apr; 5(4):807-14. PubMed ID: 10213216
[TBL] [Abstract][Full Text] [Related]
29. Relationship of methyl purines produced by MNNG in adenovirus 5 DNA to viral inactivation in repair-deficient (Mer-) human tumor cell strains.
Day RS; Yarosh DB; Ziolkowski CH
Mutat Res; 1984 Feb; 131(2):45-52. PubMed ID: 6700617
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic effects of the methylating agent 5-(3-methyl-1-triazeno) imidazole-4-carboxamide in human melanoma cells.
Hayward IP; Parsons PG
Aust J Exp Biol Med Sci; 1984 Oct; 62 ( Pt 5)():597-606. PubMed ID: 6534346
[TBL] [Abstract][Full Text] [Related]
31. Cytotoxicity of 5-(3-methyl-1-triazeno)imidazole-4-carboxamide (MTIC) on Mer+, Mer+Rem- and Mer- cell lines: differential potentiation by 3-acetamidobenzamide.
Lunn JM; Harris AL
Br J Cancer; 1988 Jan; 57(1):54-8. PubMed ID: 2831926
[TBL] [Abstract][Full Text] [Related]
32. Suppression of malignant phenotype, changes in gene expression and DNA hypermethylation in human melanoma cells treated with arabinosyl cytosine.
Drahovsky D; Brzoska MJ; Werle A; Boehm TL
Prog Clin Biol Res; 1985; 198():271-8. PubMed ID: 4070308
[No Abstract] [Full Text] [Related]
33. Cytotoxicity studies of human melanoma cells and fibroblasts.
Parsons PG; Brown SG
Aust J Exp Biol Med Sci; 1979 Apr; 57(2):161-70. PubMed ID: 485982
[TBL] [Abstract][Full Text] [Related]
34. Adenovirus replication as an in vitro probe for drug sensitivity in human tumors.
Parsons PG; Maynard KR; Little JH; McLeod GR
Eur J Cancer Clin Oncol; 1986 Apr; 22(4):401-9. PubMed ID: 3525182
[TBL] [Abstract][Full Text] [Related]
35. Sensitivity of human neuroblastoma to activated dacarbazine: relationships between cell survival, methyltransferase activity and activation of adenovirus-5.
Lihou MG; Smith PJ; Parsons PG
Eur J Cancer Clin Oncol; 1988 Jun; 24(6):991-8. PubMed ID: 3409948
[TBL] [Abstract][Full Text] [Related]
36. Effects of 5-(3-methyl-1-triazeno)imidazole-4-carboxamide (NSC-407347), an alkylating agent derived from 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388).
Mizuno NS; Decker RW; Zakis B
Biochem Pharmacol; 1975 Mar; 24(5):615-9. PubMed ID: 1168474
[No Abstract] [Full Text] [Related]
37. The mechanism of alkylation of DNA by 5-(3-methyl-1-triazeno)imidazole-4-carboxamide (MIC), a metabolite of DIC (NSC-45388). Non-involvement of diazomethane.
Nagasawa HT; Shirota FN; Mizuno NS
Chem Biol Interact; 1974 Jun; 8(6):403-13. PubMed ID: 4858713
[No Abstract] [Full Text] [Related]
38. KSHV infects a subset of human tonsillar B cells, driving proliferation and plasmablast differentiation.
Hassman LM; Ellison TJ; Kedes DH
J Clin Invest; 2011 Feb; 121(2):752-68. PubMed ID: 21245574
[TBL] [Abstract][Full Text] [Related]
39. Competency in mismatch repair prohibits clonal expansion of cancer cells treated with N-methyl-N'-nitro-N-nitrosoguanidine.
Carethers JM; Hawn MT; Chauhan DP; Luce MC; Marra G; Koi M; Boland CR
J Clin Invest; 1996 Jul; 98(1):199-206. PubMed ID: 8690794
[TBL] [Abstract][Full Text] [Related]
40. Potentiation of temozolomide and BCNU cytotoxicity by O(6)-benzylguanine: a comparative study in vitro.
Wedge SR; Porteus JK; May BL; Newlands ES
Br J Cancer; 1996 Feb; 73(4):482-90. PubMed ID: 8595163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
